Growth Hormone
Growth Hormone is a pharmaceutical drug with 70 clinical trials. Currently 4 active trials ongoing. Historical success rate of 91.5%.
Success Metrics
Based on 43 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
16
Mid Stage
20
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
82.7%
43 of 52 finished
17.3%
9 ended early
4
trials recruiting
70
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Growth Hormone for the Treatment of Gastroparesis
Effects of GH and Lirglutide on AgRP
Growth Hormone in Decompensated Liver Cirrhosis
Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy
Adipose Tissue and Serum Inflammation in GH Deficiency
Clinical Trials (70)
Growth Hormone for the Treatment of Gastroparesis
Effects of GH and Lirglutide on AgRP
Growth Hormone in Decompensated Liver Cirrhosis
Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy
Adipose Tissue and Serum Inflammation in GH Deficiency
A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism
Effect of GH on the Blastocyst Euploid Rate in AMA Patients
Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)
Assessment of Mechanisms of Improved Wound Healing
Growth Hormone Therapy in Liver Cirrhosis
Effect of GH Supplementation on the Blastocyst Euploid Rate in AMA Patients--A Retrospective Cohort Study
Growth Hormone Replacement Therapy for Retried Professional Football Players
Growth Hormone Deficiency in Mild Traumatic Brain Injury
Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease
Growth Hormone to Improve the Clinical Outcome of Assisted Fertility in Young Patients With Decreased Ovarian Reserve
Effect of GH Administration in Poor Responders Undergoing Intracytoplasmic Sperm Injection (ICSI)
Growth Hormone Adding to Controlled Ovarian Hyperstimulation for Improving Embryo Quality
Antagonist Protocol in Poor Responders
Growth Hormone Pretreatment in Poseidon Type IV Undergoing ICSI Using Minimal Induction Protocol: A Randomized Controlled Trial
GH in Adults With PWS, Effect on Hypotonia Evaluated by Functional MRI, Relationship With Strength and Body Composition
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 70